Cargando…

Selective phosphodiesterase inhibitors: a promising target for cognition enhancement

RATIONALE: One of the major complaints most people face during aging is an impairment in cognitive functioning. This has a negative impact on the quality of daily life and is even more prominent in patients suffering from neurodegenerative and psychiatric disorders including Alzheimer’s disease, sch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reneerkens, Olga A. H., Rutten, Kris, Steinbusch, Harry W. M., Blokland, Arjan, Prickaerts, Jos
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2008
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704616/ https://www.ncbi.nlm.nih.gov/pubmed/18709359 http://dx.doi.org/10.1007/s00213-008-1273-x

Ejemplares similares

Translational Issues with the Development of Cognition Enhancing Drugs
por: Blokland, Arjan, et al.
Publicado: (2014)

Phosphodiesterase Inhibition and Regulation of Dopaminergic Frontal and Striatal Functioning: Clinical Implications
por: Heckman, Pim R. A., et al.
Publicado: (2016)

Why an M1 Antagonist Could Be a More Selective Model for Memory Impairment than Scopolamine
por: Blokland, Arjan, et al.
Publicado: (2016)

Purinergic Signaling and Hippocampal Long-Term Potentiation
por: Düster, Robert, et al.
Publicado: (2014)

Possible overlapping time frames of acquisition and consolidation phases in object memory processes: a pharmacological approach
por: Akkerman, Sven, et al.
Publicado: (2016)

Cerebral Accumulation of Dietary Derivable Plant Sterols does not Interfere with Memory and Anxiety Related Behavior in Abcg5−/− Mice
por: Vanmierlo, Tim, et al.
Publicado: (2011)

Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques
por: Rutten, K., et al.
Publicado: (2007)

Targeting Phosphodiesterases—Towards a Tailor-Made Approach in Multiple Sclerosis Treatment
por: Schepers, Melissa, et al.
Publicado: (2019)

Targeting cyclic nucleotides in CNS drug discovery: a translational approach into cognition enhancement
por: Prickaerts, Jos
Publicado: (2015)

Acute administration of roflumilast enhances sensory gating in healthy young humans in a randomized trial
por: Heckman, Pim R. A., et al.
Publicado: (2017)

Preclinical profile of ITI-214, an inhibitor of phosphodiesterase 1, for enhancement of memory performance in rats
por: Snyder, Gretchen L., et al.
Publicado: (2016)

Phosphodiesterase inhibitors roflumilast and vardenafil prevent sleep deprivation‐induced deficits in spatial pattern separation
por: Heckman, Pim R. A., et al.
Publicado: (2020)

The effects of the soluble guanylate cyclase stimulator riociguat on memory performance in healthy volunteers with a biperiden-induced memory impairment
por: Borghans, Laura G. J. M., et al.
Publicado: (2018)

Neuroinflammation in Ischemic Stroke: Inhibition of cAMP-Specific Phosphodiesterases (PDEs) to the Rescue
por: Ponsaerts, Laura, et al.
Publicado: (2021)

Fluoxetine during Development Reverses the Effects of Prenatal Stress on Depressive-Like Behavior and Hippocampal Neurogenesis in Adolescence
por: Rayen, Ine, et al.
Publicado: (2011)

Selective Phosphodiesterase Inhibitors for Psoriasis: Focus on Apremilast
por: Gooderham, Melinda, et al.
Publicado: (2015)

Phosphodiesterase 4 inhibition after retrieval switches the memory fate favoring extinction instead of reconsolidation
por: Machado Batista Sohn, Jeferson, et al.
Publicado: (2023)

A Mechanistic Rationale for PDE-4 Inhibitors to Treat Residual Cognitive Deficits in Acquired Brain Injury
por: Schreiber, Rudy, et al.
Publicado: (2020)

PDE5 Inhibition Improves Object Memory in Standard Housed Rats but Not in Rats Housed in an Enriched Environment: Implications for Memory Models?
por: Akkerman, Sven, et al.
Publicado: (2014)

Prenatal stress and subsequent exposure to chronic mild stress influence dendritic spine density and morphology in the rat medial prefrontal cortex
por: Michelsen, Kimmo A, et al.
Publicado: (2007)

Selective Phosphodiesterase 4B Inhibitors: A Review
por: Azam, Mohammed Afzal, et al.
Publicado: (2014)

Memory-enhancing effects of GEBR-32a, a new PDE4D inhibitor holding promise for the treatment of Alzheimer’s disease
por: Ricciarelli, Roberta, et al.
Publicado: (2017)

Development of Phosphodiesterase–Protein-Kinase Complexes as Novel Targets for Discovery of Inhibitors with Enhanced Specificity
por: Tulsian, Nikhil K., et al.
Publicado: (2021)

Respiratory Cilia as a Therapeutic Target of Phosphodiesterase Inhibitors
por: Joskova, Marta, et al.
Publicado: (2020)

Expression of Monoamine Transporters, Nitric Oxide Synthase 3, and Neurotrophin Genes in Antidepressant-Stimulated Astrocytes
por: Kittel-Schneider, Sarah, et al.
Publicado: (2012)

A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairment
por: Klinkenberg, Inge, et al.
Publicado: (2011)

Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition
por: Peixoto, Christina Alves, et al.
Publicado: (2015)

Current concepts in Alzheimer’s Disease: molecules, models and translational perspectives
por: Rutten, Bart PF, et al.
Publicado: (2013)

The Selective Phosphodiesterase 4 Inhibitor Roflumilast and Phosphodiesterase 3/4 Inhibitor Pumafentrine Reduce Clinical Score and TNF Expression in Experimental Colitis in Mice
por: Rieder, Florian, et al.
Publicado: (2013)

Evolution of Phosphodiesterase-5 Inhibitors
por: Moon, Du Geon
Publicado: (2015)

Effect of phosphodiesterase inhibitors in the bladder
por: Chughtai, Bilal, et al.
Publicado: (2015)

Long-Term Corticosterone Exposure Decreases Insulin Sensitivity and Induces Depressive-Like Behaviour in the C57BL/6NCrl Mouse
por: van Donkelaar, Eva L., et al.
Publicado: (2014)

Amlodipine limits microglia activation and cognitive dysfunction in aged hypertensive mice
por: Kerkhofs, Danielle, et al.
Publicado: (2023)

Surface Binding Energy Landscapes Affect Phosphodiesterase Isoform-Specific Inhibitor Selectivity
por: Liu, Qing, et al.
Publicado: (2018)

Effect of Phosphodiesterase Inhibitor on Diabetic Nephropathy
por: Kang, Shin-Wook
Publicado: (2012)

Repurposing phosphodiesterase-5 inhibitors as chemoadjuvants
por: Tiwari, Amit K., et al.
Publicado: (2013)

Phosphodiesterase inhibitors as adjunctive therapies for tuberculosis
por: Ahidjo, Bintou Ahmadou, et al.
Publicado: (2016)

New Avenues for Phosphodiesterase Inhibitors in Asthma
por: Matera, Maria Gabriella, et al.
Publicado: (2021)

The effects of selective serotonin reuptake inhibitors on memory functioning in older adults: A systematic literature review
por: Schulkens, Julie EM, et al.
Publicado: (2022)

Promising New Inhibitors of Tyrosyl-DNA Phosphodiesterase I (Tdp 1) Combining 4-Arylcoumarin and Monoterpenoid Moieties as Components of Complex Antitumor Therapy
por: Khomenko, Tatyana M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vo6df7l8q27pq88kf5cqbchiim